via touchEndocrinology. Watch three leading experts explore how the pathophysiology of achondroplasia is being targeted by new and emerging pharmacotherapies to restore endochondral ossification. A roadmap to optimized current and future clinical management is also outlined.
The Chandler Project (TCP) provides those affected with achondroplasia, and other forms of skeletal dysplasia (dwarfism), with the latest in pharmaceutical research and surgical advancements. Since 2019, TCP has hosted the only conference in North America that brings together individuals and their families, physicians, researchers, biotech industries and more together at the annual Achondroplasia Research Conference.